Skip to main content
TipRanks
Go Ultimate75% OFF

Onco-Innovations Ltd. (ONCO) Financial Statements

20 Followers

Onco-Innovations Ltd. Financial Overview

Onco-Innovations Ltd.'s market cap is currently C$101.76M. The company's EPS TTM is C$-0.07; its P/E ratio is -20.06; Onco-Innovations Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Apr 24Apr 23
Income Statement
Total RevenueC$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ 0.00
Operating IncomeC$ 0.00C$ 0.00
EBITDAC$ -265.63KC$ -234.00
Net IncomeC$ -420.65KC$ -234.00
Balance Sheet
Cash & Short-Term InvestmentsC$ 499.91KC$ 18.52K
Total AssetsC$ 555.95KC$ 18.52K
Total DebtC$ 0.00C$ 0.00
Net DebtC$ -499.91KC$ -18.52K
Total LiabilitiesC$ 193.06KC$ 0.00
Stockholders' EquityC$ 362.89KC$ 18.52K
Cash Flow
Free Cash FlowC$ -6.30KC$ -233.00
Operating Cash FlowC$ -6.30KC$ -233.00
Investing Cash FlowC$ 0.00C$ 0.00
Financing Cash FlowC$ 80.00KC$ 18.75K

Currency in CAD

Onco-Innovations Ltd. Earnings and Revenue History

-450K-300K-150K00 %0.4 %0.8 %1.2 %EarningsProfit Margin20222023RevenueEarningsProfit Margin

Onco-Innovations Ltd. Liabilities to Assets

0200K400K600K0 %15 %30 %45 %LiabilitiesLiabilities to Assets20222023AssetsLiabilitiesLiabilities to Assets

Onco-Innovations Ltd. Cash Flow

-20K020K40K60K80K100K20222023OperatingInvestingFinancing

Onco-Innovations Ltd. Forecast EPS vs Actual EPS

-0.1-0.10000Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27EPS EstimateBeatMiss